ServicesCommercial Services & SuppliesTrading & Distributors

Remedium Lifecare Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 28 filings·Updated 30 Jun 2026
Showing 10 of 28 filings.
30 Jun 20261 filing
Company UpdateGeneral

NCLAT order pauses CoC voting and property sales in Supha Pharmachem CIRP until June 29, 2026

NCLAT order in CIRP

  • NCLAT disposed the Medec Infra appeal with interim observations; order dated 22 May 2026.
  • CoC to not vote on any Resolution Plan until 29 June 2026.
  • No sale of immovable property of the Corporate Debtor during this period.
  • Appeal disposed; matter fixed for hearing on 29 June 2026.
  • Appellant Medec Infra is alleged to be the sole financial creditor in CoC.
  • Interim relief can be sought before Adjudicating Authority; respondents may seek modification.
  • Company will monitor implications and inform stock exchanges of material developments.
Filed 15:53View Source
17 Apr 20261 filing
Company UpdateGeneral

Disclosure to take note of decisions taken in 1st COC meeting held on 14.04.2026

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 21:49View Source
25 Mar 20261 filing
Insider Trading / SASTClosure of Trading Window

Closure of Trading window

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 12:08View Source
21 Mar 20261 filing
Company UpdateGeneral

Intimation of receipt of Order from National Company Law Tribunal (NCLT)

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 18:00View Source
20 Mar 20261 filing
Company UpdateGeneral

Submission of Form A - PUBLIC ANNOUNCEMENT

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 22:41View Source
19 Mar 20261 filing
Company UpdateAppointment of Interim Resolution Professional (IRP)

Supha Pharmachem Ltd - 539561 - Announcement under Regulation 30 (LODR)-Appointment of Interim Resolution Professional (IRP)

CIRP Admission and Details

  • NCLT Mumbai admitted CIRP application on 17 March 2026 under Section 9 IBC.
  • Operational creditor: Boston Ivy Healthcare Solution Pvt Ltd.
  • Default amount: ₹7.47 crore including interest, default date 7 Nov 2023.
  • Moratorium effective 17 March 2026 prohibits suits, asset transfer, security enforcement, recovery.
  • IRP appointed: Mr. Rajesh Jhunjhunwala (IBBI Reg. No. IBBI/IPA-003/IP-N00457/2017-18/11102).
  • Board powers suspended; IRP vested with management control.
  • IRP to make public announcement and call for claims submission.
Filed 18:29View Source
17 Mar 20261 filing
Company UpdateGeneral

Intimation of change in registered office of the company to office no. F81D, Express Zone Mall, A wing Next to Patel Vanika, W.E. Highway, Goregaon, (East), Mumbai - 400063, w.e.f. 17th ....

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 10:51View Source
9 Mar 20261 filing
Company UpdateBoard Meeting Rescheduled

Supha Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/03/2026 ,inter alia, to consider and approve To consider Un-Audited Financial ....

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 19:30View Source
25 Feb 20261 filing
Company UpdateBoard Meeting Rescheduled

Supha Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/03/2026 ,inter alia, to consider and approve unaudited standalone and consolidated ....

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 16:19View Source
17 Feb 20261 filing
Company UpdateBoard Meeting Rescheduled

Supha Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/02/2026 ,inter alia, to consider and approve unaudited standalone and consolidated ....

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 13:29View Source
Showing 10 of 28 filings